The significance of micro-lymphatic invasion and pathological Gleason score in prostate cancer patients with pathologically organ-confined disease and negative surgical margins after robot-assisted radical prostatectomy

[1]  A. Haese*,et al.  Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer. , 2018, European urology.

[2]  B. Tombal,et al.  Predictive factors associated with biochemical recurrence following radical prostatectomy for pathological T2 prostate cancer with negative surgical margins , 2017, Scandinavian journal of urology.

[3]  J. Nesland,et al.  Combining lymphovascular invasion with reactive stromal grade predicts prostate cancer mortality , 2016, The Prostate.

[4]  Y. Lotan,et al.  Validation of lymphovascular invasion is an independent prognostic factor for biochemical recurrence after radical prostatectomy. , 2016, Urologic oncology.

[5]  S. Groshen,et al.  Significance of lymphovascular invasion in organ‐confined, node‐negative urothelial cancer of the bladder: data from the prospective p53‐MVAC trial , 2015, BJU international.

[6]  Y. Horiguchi,et al.  Prediction of biochemical recurrence after robot‐assisted radical prostatectomy: Analysis of 784 Japanese patients , 2015, International journal of urology : official journal of the Japanese Urological Association.

[7]  T. Habuchi,et al.  Lymphovascular invasion is significantly associated with biochemical relapse after radical prostatectomy even in patients with pT2N0 negative resection margin , 2014, Prostate Cancer and Prostatic Disease.

[8]  Hans Garmo,et al.  Radical prostatectomy or watchful waiting in early prostate cancer. , 2014, The New England journal of medicine.

[9]  Markus Graefen,et al.  Positive surgical margins after radical prostatectomy: a systematic review and contemporary update. , 2014, European urology.

[10]  T. Ahlering,et al.  Robot-assisted radical prostatectomy: 5-year oncological and biochemical outcomes. , 2012, The Journal of urology.

[11]  L. Egevad,et al.  Biochemical recurrence after robot-assisted radical prostatectomy in a European single-centre cohort with a minimum follow-up time of 5 years. , 2012, European urology.

[12]  Timothy J Wilt,et al.  Radical prostatectomy versus observation for localized prostate cancer. , 2012, The New England journal of medicine.

[13]  W. Lowrance,et al.  Prognostic significance of lymphovascular invasion in radical prostatectomy specimens , 2011, BJU international.

[14]  A. Haese*,et al.  Biochemical recurrence after radical prostatectomy: multiplicative interaction between surgical margin status and pathological stage. , 2010, The Journal of urology.

[15]  K. Togashi,et al.  Evaluation of Venous Invasion by Elastica van Gieson Stain and Tumor Budding Predicts Local and Distant Metastases in Patients With T1 Stage Colorectal Cancer , 2009, The American journal of surgical pathology.

[16]  H. Miyake,et al.  Distribution of the lymphatic vessels in the prostatic fascia , 2009, The Prostate.

[17]  Hans Garmo,et al.  Radical prostatectomy versus watchful waiting in early prostate cancer. , 2005, The New England journal of medicine.

[18]  I. Sesterhenn,et al.  World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs , 2005 .

[19]  C. Roehrborn,et al.  Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy. , 2004, The Journal of urology.

[20]  Jun Nakashima,et al.  Prognostic Implication of Microvascular Invasion in Biochemical Failure in Patients Treated with Radical Prostatectomy , 2003, Urologia Internationalis.

[21]  P. Royston,et al.  Metastatic renal carcinoma comprehensive prognostic system , 2003, British Journal of Cancer.

[22]  M. Kattan,et al.  Lymphovascular invasion as a predictor of disease progression in prostate cancer. , 2000, The American journal of surgical pathology.

[23]  J. Gschwend,et al.  Prognostic Factors for Biochemical Recurrence More than 10 Years after Radical Prostatectomy , 2017, The Journal of urology.

[24]  Thomas Wiegel,et al.  EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. , 2011, European urology.

[25]  Hans Garmo,et al.  Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer , 2011 .

[26]  A. Marx,et al.  World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs , 2004 .

[27]  N. E. Mckinnon.  Cancer Mortality , 1942, Nature.